Full Story What happens when you stop weight-loss jabs?
Oct 6, 2025
Join Amy Young, a Kent-based career coach, and Ian Sample, science editor at The Guardian, as they dive into the emotional and clinical impacts of stopping GLP-1 weight-loss injections. Amy shares her journey of significant weight loss through Manjaro and the shock of sudden price hikes that forced her to stop. Ian explains the mechanisms of GLP-1 drugs, the challenges of weight regain, and the wider implications for over a million users in the UK, highlighting the urgent need for support as many navigate raising costs and mental health concerns.
AI Snips
Chapters
Transcript
Episode notes
Rapid Personal Transformation
- Amy Young lost three and a half stone (23 kg) in eight months on Manjaro and felt dramatic health improvements.
- Her creaky knees disappeared and she began training for the Surrey Three Peaks.
Sudden Price Shock
- Amy received three days' notice that the monthly cost would jump from £99 to about £310 for Manjaro.
- She was forced to choose between paying far more or stopping the drug immediately.
Trial Pricing Then Abandonment
- Amy joined an adherence study that charged £99/month and allowed dose increases at the same price.
- She felt abandoned when providers offered no support and cited manufacturer pricing as the reason.